Dec. 15, 2005 — Oxonica plc, a European nanotechnology group, announced that it signed an exclusive agreement with Croda, a global speciality chemicals group, to distribute Oxonica’s Optisol UV absorber into the international personal care market.
Optisol was launched in 2004, and is currently incorporated within the Boots Soltan Facial range of products. Oxonica said that over the past year it has focused on increasing the awareness of Optisol within major cosmetic houses and that it has achieved several successful evaluations.
The partnership with Croda is geared towards crystallizing some of the early evaluations, the company said. Croda will provide its sales channel and technical expertise to broaden the commercialization of Optisol, with an initial focus on the Americas, Europe and Australia.